A carregar...
Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials
While current lymphoma therapies induce remission in most dogs, drug‐resistant relapse is common, creating a need for novel agents. Rabacfosadine (RAB), a double prodrug of the acyclic nucleotide phosphonate 9‐(2‐phosphonylmethoxyethel) guanine (PMEG), preferentially targets lymphoma cells with redu...
Na minha lista:
| Publicado no: | Vet Comp Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754483/ https://ncbi.nlm.nih.gov/pubmed/32346934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12605 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|